Sumit Thakar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sumit Thakar has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Alangar S. Hegde
Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore, India
32 shared publicationsSaritha Aryan
Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Whitefield, EPIP Area, Bangalore, India
29 shared publicationsDilip Mohan
Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Whitefield, Bengaluru, Karnataka, India
15 shared publicationsNandita Ghosal
Department of Pathology, Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore, India
11 shared publicationsNarayanam Anantha Sai Kiran
Department and Institution, Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Whitefield, Bangalore- 560066, India
7 shared publications- Laxminadh Sivaraju
Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore, India
6 shared publications
Latest Publications
- 29 July 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 153, 112223
A third leg: Supernumerary lower limb in complex spinal dysraphism
- 29 July 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 153, 112223
A third leg: Supernumerary lower limb in complex spinal dysraphism
- Open Access
- 11 March 2026
- Published by Wolters Kluwer Health in Neurology India
- Vol. 74 (2) , 234-240
Serum Metabolomic Signature of Gliomas in an Indian Cohort: Identification of Grade-Specific Alterations and Potential Biomarkers
Background: Metabolic reprogramming plays a key role in glioma biology, tumor growth, survival, and resistance to treatment. Given the racial and ethnic differences in glioma epidemiology, metabolomic profiling offers a promising approach to identifying population-specific biomarkers. Objective: This study aimed to evaluate whether serum metabolomic profiling can effectively capture glioma-associated metabolic alterations, investigate grade-specific differences, and compare these profiles with healthy controls—addressing the current scarcity of such research in the Indian population. Methods: Serum samples were collected from 60 treatment-naïve glioma patients (WHO Grades I–IV) and 10 healthy controls between September 2019 and September 2023. Targeted metabolomic profiling of 150 metabolites was performed using liquid chromatography–mass spectrometry. The data were normalized and subjected to quality control, with metabolites having a coefficient of variation >20% excluded. Data analysis was conducted using MetaboAnalyst 5.0. Significant metabolic alterations with a false discovery rate ≤0.25 were identified. Pathway enrichment analysis was performed to identify grade-related metabolic alterations. Results: Forty-one metabolites were found to be significantly altered in glioma patients compared to controls, especially those related to the metabolism of arginine, tryptophan, and inositol phosphate. Thirty-four metabolites were significantly different in low-grade gliomas, involving pathways such as phenylalanine, tyrosine, and tryptophan biosynthesis. Comparison between low- and high-grade tumors revealed 49 altered metabolites, with high-grade gliomas demonstrating increased activity in the metabolism of glutathione and glycerophospholipids, as well as the biosynthesis of branched-chain amino acids. Grade IV gliomas demonstrated the most extensive metabolic changes, including alterations in pantothenate and coenzyme A biosynthesis and histidine metabolism. Conclusions: This targeted metabolomic analysis highlights distinct metabolic reprogramming across glioma grades in an Indian cohort. These findings provide insights into glioma biology in the Indian context and highlight the potential of metabolomics in tumor grading, disease monitoring, and personalized therapeutic approaches.
- 11 March 2026
- Published by Wolters Kluwer Health in Neurology India
- Vol. 74 (2) , 234-240
Open AccessSerum Metabolomic Signature of Gliomas in an Indian Cohort: Identification of Grade-Specific Alterations and Potential Biomarkers
Background: Metabolic reprogramming plays a key role in glioma biology, tumor growth, survival, and resistance to treatment. Given the racial and ethnic differences in glioma epidemiology, metabolomic profiling offers a promising approach to identifying population-specific biomarkers. Objective: This study aimed to evaluate whether serum metabolomic profiling can effectively capture glioma-associated metabolic alterations, investigate grade-specific differences, and compare these profiles with healthy controls—addressing the current scarcity of such research in the Indian population. Methods: Serum samples were collected from 60 treatment-naïve glioma patients (WHO Grades I–IV) and 10 healthy controls between September 2019 and September 2023. Targeted metabolomic profiling of 150 metabolites was performed using liquid chromatography–mass spectrometry. The data were normalized and subjected to quality control, with metabolites having a coefficient of variation >20% excluded. Data analysis was conducted using MetaboAnalyst 5.0. Significant metabolic alterations with a false discovery rate ≤0.25 were identified. Pathway enrichment analysis was performed to identify grade-related metabolic alterations. Results: Forty-one metabolites were found to be significantly altered in glioma patients compared to controls, especially those related to the metabolism of arginine, tryptophan, and inositol phosphate. Thirty-four metabolites were significantly different in low-grade gliomas, involving pathways such as phenylalanine, tyrosine, and tryptophan biosynthesis. Comparison between low- and high-grade tumors revealed 49 altered metabolites, with high-grade gliomas demonstrating increased activity in the metabolism of glutathione and glycerophospholipids, as well as the biosynthesis of branched-chain amino acids. Grade IV gliomas demonstrated the most extensive metabolic changes, including alterations in pantothenate and coenzyme A biosynthesis and histidine metabolism. Conclusions: This targeted metabolomic analysis highlights distinct metabolic reprogramming across glioma grades in an Indian cohort. These findings provide insights into glioma biology in the Indian context and highlight the potential of metabolomics in tumor grading, disease monitoring, and personalized therapeutic approaches.
- 26 December 2024
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 132, 111010
Giant brain Stone: Calcifying pseudoneoplasm of the neuraxis (CAPNON)
- 26 December 2024
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 132, 111010
Giant brain Stone: Calcifying pseudoneoplasm of the neuraxis (CAPNON)
- 10 December 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (11) , e210066
Teaching NeuroImage: Basal Encephaloceles With CSF Rhinorrhea in a Patient With Osteopetrosis
- 10 December 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (11) , e210066
Teaching NeuroImage: Basal Encephaloceles With CSF Rhinorrhea in a Patient With Osteopetrosis
- 27 November 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-6
Radiation-induced Moyamoya syndrome—missed diagnosis with a fatal outcome in a recurrent craniopharyngioma
Secondary Moyamoya syndrome (MMS) is a rare but serious complication of radiotherapy (RT) in patients with craniopharyngiomas. This report details the fatal clinical course in a 4-year-old girl with a recurrent craniopharyngioma and a missed diagnosis of RT-induced Moyamoya syndrome. Her clinical condition deteriorated a day after uneventful re-exploratory transcranial surgery. She succumbed to bilateral internal carotid artery territory infarcts that were angiographically confirmed to be secondary to MMS. This case underscores the importance of diagnosing RT-induced vasculopathy, a complication that can occur as early as 10 months after completion of RT. Treatment of the condition includes medical management and performing revascularization procedure(s). If these patients require re-exploratory surgery for tumor recurrence, a trans-nasal approach should be used. This avoids the disruption of existing trans-dural collaterals—a phenomenon that could occur with transcranial surgery.
- 27 November 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-6
Radiation-induced Moyamoya syndrome—missed diagnosis with a fatal outcome in a recurrent craniopharyngioma
Secondary Moyamoya syndrome (MMS) is a rare but serious complication of radiotherapy (RT) in patients with craniopharyngiomas. This report details the fatal clinical course in a 4-year-old girl with a recurrent craniopharyngioma and a missed diagnosis of RT-induced Moyamoya syndrome. Her clinical condition deteriorated a day after uneventful re-exploratory transcranial surgery. She succumbed to bilateral internal carotid artery territory infarcts that were angiographically confirmed to be secondary to MMS. This case underscores the importance of diagnosing RT-induced vasculopathy, a complication that can occur as early as 10 months after completion of RT. Treatment of the condition includes medical management and performing revascularization procedure(s). If these patients require re-exploratory surgery for tumor recurrence, a trans-nasal approach should be used. This avoids the disruption of existing trans-dural collaterals—a phenomenon that could occur with transcranial surgery.
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Neurology India
- Vol. 72 (5) , 1054-1062
Value-Based, No-Cost-To-Patient Neurosurgery at Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore: The Success Story
The Sri Sathya Sai Central Trust (SSSCT) was founded in 1972 as a public charitable trust with the objectives of providing free education, healthcare, and public utility benefits without any discrimination. The neurosurgery department at the Sri Sathya Sai Institute of Higher Medical Sciences (SSSIHMS), Bangalore, one of SSSCT’s many hospitals, has been offering comprehensive services with state-of-the-art facilities for a diverse range of disorders since 2001. Operating on a unique “no-cost-to-patient” model and guided by an ethos of altruism introduced by its founder Sri Sathya Sai Baba, the department has successfully provided high-quality neurosurgical care to a large number of patients. This article reviews the genesis of the department, its milestones over more than two decades, and the contributions of leaders who have played an important role in shaping the department.
- 1 September 2024
- Published by Wolters Kluwer Health in Neurology India
- Vol. 72 (5) , 1054-1062
Open AccessValue-Based, No-Cost-To-Patient Neurosurgery at Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore: The Success Story
The Sri Sathya Sai Central Trust (SSSCT) was founded in 1972 as a public charitable trust with the objectives of providing free education, healthcare, and public utility benefits without any discrimination. The neurosurgery department at the Sri Sathya Sai Institute of Higher Medical Sciences (SSSIHMS), Bangalore, one of SSSCT’s many hospitals, has been offering comprehensive services with state-of-the-art facilities for a diverse range of disorders since 2001. Operating on a unique “no-cost-to-patient” model and guided by an ethos of altruism introduced by its founder Sri Sathya Sai Baba, the department has successfully provided high-quality neurosurgical care to a large number of patients. This article reviews the genesis of the department, its milestones over more than two decades, and the contributions of leaders who have played an important role in shaping the department.
- 31 August 2024
- Published by Elsevier in World Neurosurgery
- Vol. 191, e393-e402
Optico-Chiasmatic Distortions in Pituitary Adenomas: Correlation Between Postoperative Morphological Reversal and Follow-Up Functional Visual Recovery
- 31 August 2024
- Published by Elsevier in World Neurosurgery
- Vol. 191, e393-e402
Optico-Chiasmatic Distortions in Pituitary Adenomas: Correlation Between Postoperative Morphological Reversal and Follow-Up Functional Visual Recovery
- 24 August 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (12) , 4289-4294
Primary intracranial pediatric ganglioneuroblastoma—report of two cases and review of an unusual masquerader
Ganglioneuroblastoma (GNB) is a rare neurogenic tumor with a predilection for extracranial sites. Its primary intracranial occurrence is anecdotal, with less than ten cases reported in pediatric literature. We report two cases of this unusual entity. The first was a 1-year-old boy who presented with a progressive scalp swelling that radiologically appeared to be a mesenchymal tumor. The tumor was resected completely, and its histopathological examination was suggestive of a pigmented GNB. The clinico-radiological presentation and melanin pigmentation of the tumor were unique features of the case. The second case was a 7-year-old girl who presented with left hemiparesis and raised intracranial pressure due to a large right parietal intraparenchymal tumor that histologically proved to be a GNB. The child succumbed to disease progression a month after undergoing near-total resection of the tumor. Analysis of our cases in the light of a literature review reveals that pediatric intracranial GNBs have diverse clinico-radiological features and can easily be confused for commoner pathologies in both intra- and extra-axial locations.
- 24 August 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (12) , 4289-4294
Primary intracranial pediatric ganglioneuroblastoma—report of two cases and review of an unusual masquerader
Ganglioneuroblastoma (GNB) is a rare neurogenic tumor with a predilection for extracranial sites. Its primary intracranial occurrence is anecdotal, with less than ten cases reported in pediatric literature. We report two cases of this unusual entity. The first was a 1-year-old boy who presented with a progressive scalp swelling that radiologically appeared to be a mesenchymal tumor. The tumor was resected completely, and its histopathological examination was suggestive of a pigmented GNB. The clinico-radiological presentation and melanin pigmentation of the tumor were unique features of the case. The second case was a 7-year-old girl who presented with left hemiparesis and raised intracranial pressure due to a large right parietal intraparenchymal tumor that histologically proved to be a GNB. The child succumbed to disease progression a month after undergoing near-total resection of the tumor. Analysis of our cases in the light of a literature review reveals that pediatric intracranial GNBs have diverse clinico-radiological features and can easily be confused for commoner pathologies in both intra- and extra-axial locations.
- 6 August 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-5
Cervical intraosseous arteriovenous malformation: report of a rare entity and its management dilemmas
Intraosseous occurrence of a spinal AVM is anecdotal, with only four such cases reported previously. This is the first report of a spinal intraosseous AVM in the cervical vertebrae. A 44-year-old male patient presented with a 2-month history of progressive quadriparesis and bladder dysfunction. Magnetic resonance imaging showed multiple flow voids within the C4 and C5 vertebral bodies, and an extradural component causing cord compression. CT showed extensive bony destruction at both levels. The diagnosis of an intraosseous AVM was confirmed with spinal angiography. The AVM was noted to be fed by branches from the ascending cervical arteries and the vertebral artery. The nidus was draining into the vertebral venous plexus and thence into the jugular vein through the marginal sinus. The patient underwent partial embolization of the AVM. Surgical resection was attempted but found to be unfeasible due to torrential bleeding. A 360-degree stabilization along with decompressive laminectomies was performed, resulting in clinical improvement and disease stabilization at one year follow-up. The case and its management dilemmas are discussed in light of a brief literature review.
- 6 August 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-5
Cervical intraosseous arteriovenous malformation: report of a rare entity and its management dilemmas
Intraosseous occurrence of a spinal AVM is anecdotal, with only four such cases reported previously. This is the first report of a spinal intraosseous AVM in the cervical vertebrae. A 44-year-old male patient presented with a 2-month history of progressive quadriparesis and bladder dysfunction. Magnetic resonance imaging showed multiple flow voids within the C4 and C5 vertebral bodies, and an extradural component causing cord compression. CT showed extensive bony destruction at both levels. The diagnosis of an intraosseous AVM was confirmed with spinal angiography. The AVM was noted to be fed by branches from the ascending cervical arteries and the vertebral artery. The nidus was draining into the vertebral venous plexus and thence into the jugular vein through the marginal sinus. The patient underwent partial embolization of the AVM. Surgical resection was attempted but found to be unfeasible due to torrential bleeding. A 360-degree stabilization along with decompressive laminectomies was performed, resulting in clinical improvement and disease stabilization at one year follow-up. The case and its management dilemmas are discussed in light of a brief literature review.
- 12 June 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (1) , 111-121
Moving Beyond Morphometrics and Alignment: Prospective Longitudinal Study on Cognition, Quality of Life, and Diffusion Metrics in Congenital Craniovertebral Junction Anomalies
BACKGROUND AND OBJECTIVES: Chiari type I malformation (CMI) has been implicated to cause cognitive impairment. Unusual for a craniovertebral junction (CVJ) anomaly, this phenomenon is postulated to be related to microstructural changes across the brain. However, this has not been confirmed in a longitudinal study, in bony CVJ anomalies, or in the context of quality of life (QOL). This study aimed to analyze cognition, QOL, and diffusion tensor imaging (DTI) metrics before and after surgery for congenital CVJ anomalies and evaluate their correlations with conventional clinico-radiological factors.METHODS: Fifty-seven patients with congenital CVJ anomalies—CMI, atlantoaxial dislocation (AAD), and basilar invagination (BI)—were evaluated in this prospective longitudinal study over 3 years with a neuropsychological battery, QOL and functional scores, and DTI metrics. A total of 43 patients (23 with CMI; 20 with AAD or BI) with 1-year postsurgical data were included in the final analysis.RESULTS: Cognitive dysfunction in one or more domains was noted in 15 (65%) of the patients with CMI and 16 (80%) of the patients with AAD/BI. Memory and visual motor perception were the most-affected domains in both the cohorts. At the 1-year follow-up, the proportion of patients demonstrating an overall cognitive dysfunction did not change significantly (P> .05). All patients demonstrated significant postoperative improvement in functional and QOL scores at follow-up. DTI metrics improved in many regions postoperatively, but did not correlate with functional or cognitive changes (P> .05).CONCLUSION: Cognition is affected in a majority of patients with CMI, AAD, or BI. These patients experience good functional and QOL outcomes after surgery but most of them continue to exhibit cognitive impairment. DTI metrics improve after surgery, but do not correlate with cognitive changes. These findings underline the multidimensional nature of the pathology of these anomalies that complicate achieving the concept of a “successful” surgery.
- 12 June 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (1) , 111-121
Moving Beyond Morphometrics and Alignment: Prospective Longitudinal Study on Cognition, Quality of Life, and Diffusion Metrics in Congenital Craniovertebral Junction Anomalies
BACKGROUND AND OBJECTIVES: Chiari type I malformation (CMI) has been implicated to cause cognitive impairment. Unusual for a craniovertebral junction (CVJ) anomaly, this phenomenon is postulated to be related to microstructural changes across the brain. However, this has not been confirmed in a longitudinal study, in bony CVJ anomalies, or in the context of quality of life (QOL). This study aimed to analyze cognition, QOL, and diffusion tensor imaging (DTI) metrics before and after surgery for congenital CVJ anomalies and evaluate their correlations with conventional clinico-radiological factors.METHODS: Fifty-seven patients with congenital CVJ anomalies—CMI, atlantoaxial dislocation (AAD), and basilar invagination (BI)—were evaluated in this prospective longitudinal study over 3 years with a neuropsychological battery, QOL and functional scores, and DTI metrics. A total of 43 patients (23 with CMI; 20 with AAD or BI) with 1-year postsurgical data were included in the final analysis.RESULTS: Cognitive dysfunction in one or more domains was noted in 15 (65%) of the patients with CMI and 16 (80%) of the patients with AAD/BI. Memory and visual motor perception were the most-affected domains in both the cohorts. At the 1-year follow-up, the proportion of patients demonstrating an overall cognitive dysfunction did not change significantly (P> .05). All patients demonstrated significant postoperative improvement in functional and QOL scores at follow-up. DTI metrics improved in many regions postoperatively, but did not correlate with functional or cognitive changes (P> .05).CONCLUSION: Cognition is affected in a majority of patients with CMI, AAD, or BI. These patients experience good functional and QOL outcomes after surgery but most of them continue to exhibit cognitive impairment. DTI metrics improve after surgery, but do not correlate with cognitive changes. These findings underline the multidimensional nature of the pathology of these anomalies that complicate achieving the concept of a “successful” surgery.